Prostate Specific Antigen (PSA) Biosensor
Measures PSA concentrations to optimise staging of prostate cancer
A unique device providing in-vivo and ex-vivo PSA concentration measurements from tissue fluid samples in minutes
The PSA Biosensor is currently undergoing trials in Norway and the UK to establish its place in the staging of prostate cancer. CE marking is expected in 2007
Detects PSA concentrations between 1mg/L-1g/L in tissue fluid samples